Neuroinflammation in bipolar depression

F Benedetti, V Aggio, ML Pratesi, G Greco… - Frontiers in …, 2020 - frontiersin.org
Bipolar disorder (BD) is a leading cause of worldwide disability among mood disorders.
Pathological mechanisms are still vastly unclear, and current treatments with conventional …

The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies

AT Amare, KO Schubert, M Klingler-Hoffmann… - Translational …, 2017 - nature.com
Meta-analyses of genome-wide association studies (meta-GWASs) and candidate gene
studies have identified genetic variants associated with cardiovascular diseases, metabolic …

[HTML][HTML] Clinical insights into the cross-link between mood disorders and type 2 diabetes: a review of longitudinal studies and Mendelian randomisation analyses

C Possidente, G Fanelli, A Serretti, C Fabbri - … & Biobehavioral Reviews, 2023 - Elsevier
Mood disorders and type 2 diabetes mellitus (T2DM) are prevalent conditions that often co-
occur. We reviewed the available evidence from longitudinal and Mendelian randomisation …

Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: a systematic review and …

YK Liu, S Ling, LMW Lui, F Ceban, M Vinberg… - Journal of affective …, 2022 - Elsevier
Objectives The study herein aimed to assess the prevalence of type 2 diabetes mellitus
(T2DM), impaired fasting glucose (IFG), as well as general and abdominal obesity in …

Diabetes and mental health

DJ Robinson, M Coons, H Haensel, M Vallis… - Canadian journal of …, 2018 - Elsevier
Research has shown an increasingly clear relationship between diabetes and a variety of
mental health issues. These include diagnosable psychiatric disorders, and other problems …

[HTML][HTML] Treating insulin resistance with metformin as a strategy to improve clinical outcomes in treatment-resistant bipolar depression (the TRIO-BD Study): a …

CV Calkin, KNR Chengappa, K Cairns… - The Journal of clinical …, 2022 - psychiatrist.com
Objective: Therapeutic options are limited for treatment-resistant bipolar depression (TRBD).
Insulin resistance (IR) confers increased risk for TRBD. We investigated metformin, an …

Efficacy of low carbohydrate and ketogenic diets in treating mood and anxiety disorders: systematic review and implications for clinical practice

DM Dietch, J Kerr-Gaffney, M Hockey, W Marx… - BJPsych …, 2023 - cambridge.org
Background There is mounting interest in the potential efficacy of low carbohydrate and very
low carbohydrate ketogenic diets in various neurological and psychiatric disorders. Aims To …

Does metabolic syndrome or its component factors alter the course of bipolar disorder? A systematic review

A Gimenez-Palomo, S Gomes-da-Costa, S Dodd… - Neuroscience & …, 2022 - Elsevier
Metabolic syndrome (MetS) and its component factors, obesity, hypertension, dyslipidaemia
and insulin resistance, have shown a bidirectional relationship with the prevalence and …

[HTML][HTML] Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression

L Kamintsky, KA Cairns, R Veksler, C Bowen… - NeuroImage: Clinical, 2020 - Elsevier
Bipolar disorder affects approximately 2% of the population and is typically characterized by
recurrent episodes of mania and depression. While some patients achieve remission using …

Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders

G Morris, BK Puri, AJ Walker, M Maes… - Neuroscience & …, 2019 - Elsevier
Activated immune-inflammatory, oxidative and nitrosative stress (IO&NS) pathways and
consequent mitochondrial aberrations are involved in the pathophysiology of psychiatric …